SuPAR in pleural fluid may function as a biological marker for infection in critically ill patients with pleural effusions.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Infection

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jinf.2014.02.005PMID 24534606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review

  2012cited by this paper
• The use of pleural fluid procalcitonin and C-reactive protein in the diagnosis of parapneumonic pleural effusions: a systemic review and meta-analysis.

  2012cited by this paper
• Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.

  2011cited by this paper
• Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis

  2011cited by this paper
• Infectious pleural effusions can be identified by sTREM-1 levels.

  2010cited by this paper
• suPAR: The Molecular Crystal Ball

  2009cited by this paper
• Parapneumonic effusions and empyema.

  2006cited by this paper
• Correlation between levels of tumour necrosis factor-alpha and levels of pH, glucose, and lactate dehydrogenase in parapneumonic effusions.

  2005cited by this paper
• P LEURAL E FFUSION

  2002cited by this paper
• Parapneumonic effusions and empyema.

  2000cited by this paper

• A Practical Approach to Pleural Infection

  2025cites this paper
• Diagnostic value of soluble biomarkers for parapneumonic pleural effusion

  2023cites this paper
• Pleural fluid biomarkers: a narrative review

  2023cites this paper
• Diagnosis and management of pleural infection

  2023cites this paper
• Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions

  2020cites this paper
• Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia

  2019cites this paper
• Soluble urokinase plasminogen activator receptor (suPAR) for the prediction of ventilator-associated pneumonia (VAP)

  2018cites this paper
• Prognostic and diagnostic potential of suPAR levels in pleural effusion.

  2017cites this paper
• Lung-protective perioperative mechanical ventilation

  2015cites this paper